What is the mechanism of colorimetry in measuring serum components, such as albumin levels, in adult patients, especially those with impaired liver or kidney function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mechanism of Colorimetry in Measuring Serum Albumin

Basic Principle

Colorimetric methods for measuring serum albumin rely on the binding of specific dyes to albumin molecules, producing a color change that can be quantified spectrophotometrically, with bromcresol green (BCG) being the most widely used assay in clinical laboratories. 1

Bromcresol Green (BCG) Method

Mechanism of Action

  • BCG dye binds to albumin molecules at specific sites, forming a colored complex that absorbs light at a characteristic wavelength 1
  • The intensity of the color produced is directly proportional to the albumin concentration in the sample 1
  • The method uses small aliquots of plasma and has been automated for high-throughput clinical use 1

Performance Characteristics

  • The BCG method is rapid, reproducible, and has a low coefficient of variation (5.9%) 1
  • It is not affected by lipemia, salicylates, or bilirubin, making it robust for clinical samples 1
  • The normal range for BCG is 3.8-5.1 g/dL, compared to 3.5-5.0 g/dL for electrophoretic methods 1, 2

Measurement Discrepancies

  • BCG overestimates albumin in the low range by approximately 0.61 g/dL on average and differs from electrophoretic methods by about 0.3 g/dL 1, 2
  • The method underestimates albumin in the high normal range but overestimates it below the normal range 1
  • With values in the normal electrophoretic range (3.5-5.0 g/dL), BCG gives comparable results to electrophoresis 1

Bromcresol Purple (BCP) Method

Mechanism and Limitations

  • BCP is an alternative colorimetric dye that binds to albumin with greater specificity than BCG, achieving specificity similar to electrophoretic methods 1
  • However, BCP has proven less reliable clinically and underestimates serum albumin by approximately 19% in dialysis patients 1, 2
  • BCP underestimates albumin by a mean difference of 0.71 g/dL in pediatric hemodialysis patients 1

Clinical Implications

  • If BCP must be used, laboratory-specific reference ranges should be applied, and less clinical weight should be placed on absolute values 1, 2
  • Other markers of malnutrition should be more heavily weighted when BCP is the only available method 1

Gold Standard Methods

Nephelometry and Electrophoresis

  • Nephelometry and electrophoretic methods are very specific for albumin determination and serve as reference standards 1
  • These methods are time-consuming, expensive, and not generally used in routine clinical laboratories 1
  • BCG values in hemodialysis patients are virtually identical to nephelometric values, validating BCG as the preferred clinical method 1

Diagram of Colorimetric Mechanism

Serum Sample → Dye Addition (BCG or BCP) → Dye-Albumin Complex Formation
                                                    ↓
                                          Color Development
                                                    ↓
                                    Spectrophotometric Measurement
                                                    ↓
                                    Albumin Concentration Calculated

Clinical Application in Liver and Kidney Disease

Liver Disease Considerations

  • Albumin is synthesized exclusively by the liver, making serum albumin levels reduced in acute and chronic liver disease 3, 4
  • In advanced cirrhosis, albumin quality is decreased due to oxidative stress and proinflammatory states, with increased pathological isoforms 5
  • The effective albumin concentration (native intact albumin) is more clinically relevant than total albumin concentration in cirrhotic patients 4

Kidney Disease Considerations

  • In chronic renal failure patients, a reduction in serum albumin by ≥0.3 g/dL to <4.0 g/dL indicates nutritional deterioration 1, 2
  • BCG method should be requested when available for monitoring chronic kidney disease patients 1
  • Serial albumin measurements are critical for determining timing of dialysis initiation 1

Common Pitfalls to Avoid

  • Always confirm which laboratory method is being used, as different assays have different reference ranges and clinical reliability 1, 2
  • Do not assume all albumin measurements are equivalent—BCG and BCP can differ by up to 0.71 g/dL 1
  • Pre-analytical factors such as prolonged tourniquet application can cause hemoconcentration and falsely elevated albumin levels 2, 6
  • In patients with liver disease, consider that structural albumin changes may impair function despite seemingly adequate concentrations 4, 5
  • Laboratory error should always be ruled out with repeat testing before clinical decision-making 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Elevated Serum Albumin and Total Protein Levels: Assessment and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Controversies regarding albumin therapy in cirrhosis.

Hepatology (Baltimore, Md.), 2025

Research

Role of human albumin in the management of complications of liver cirrhosis.

Journal of clinical and experimental hepatology, 2014

Guideline

Elevated Total Protein and Albumin: Causes and Clinical Significance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.